IL17RC (aa 1-454) Protein (His Tag)

Interleukin 17 receptor C Protein Datasheet

IL17RC (aa 1-454) Protein Product Information

• Synonym: UNQ6118, PRO20040, PRO38901, FLJ95963, FLJ96005, IL17-RL, IL17RL, MGC10763
• Protein Construction: A DNA sequence encoding the full length of human IL17RC isoform 3 (NP_116121.2) (Met 1- Ala 454) was fused with a polyhistidine tag at the carboxy-terminus.
• Source: Human
• Expression Host: Baculovirus-Insect cells

IL17RC (aa 1-454) Protein QC Testing

• Purity: > 90 % as determined by SDS-PAGE.
• Endotoxin: < 1.0 EU per μg of the protein as determined by the LAL method
• Stability: Samples are stable for up to twelve months from date of receipt at -70℃
• Predicted N terminal: Leu 21
• Molecular Mass: The recombinant human IL17RC (aa 1-454) consists of 444 amino acids and predicts a molecular mass of 49.6 KDa. The apparent molecular mass of the protein is approximately 60KDa in SDS-PAGE under reducing conditions.
• Formulation: Lyophilized from 0.2μm filtered solution of 20mM Tris, 500mM NaCl, pH 7.4, 10% gly
  1. Normally 5 % - 8 % trehalose and mannitol are added as protectants before lyophilization. Specific concentrations are included in the hardcopy of COA.
  2. Please contact us for any concerns or special requirements.
• SDS-PAGE: IL17RC (aa 1-454) protein

IL17RC (aa 1-454) Protein Usage Guide

• Storage: Store it under sterile conditions at -70℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
• Reconstitution: A hardcopy of COA with reconstitution instruction is sent along with the products. Please refer to it for detailed information.

IL17RC (aa 1-454) Protein Description

Interleukin-17 receptor C (IL-17RC) is a single-pass transmembrane protein that shares similarity with the IL-17R. IL-17RC functions as a receptor for both IL-17A and IL-17F, both of which are considered as factors contributing to the progression of inflammatory and autoimmune diseases. IL-17A and IL-17F mediate inflammatory activities via the IL-17 receptor complex, comprised of the IL-17RA and IL-17RC subunits. Soluble version of IL-17RC should be an effective antagonist of IL-17A and IL-17F mediated inflammatory diseases. IL-17RC and IL-17RA have been found to be overexpressed in rheumatoid arthritis (RA) peripheral whole blood and their expression was detected locally in RA synovium. IL-17RC protein expression was significantly higher in androgen-independent prostate cancers than in androgen-dependent ones. This protein is differentially expressed in prostatic cells and cancer tissues and may play a negative or positive role in the initiation and progression of prostate cancer.

References

1. Allen W. et al., 2010, Semin Immunopathol. 32 (1): 33-42.
2. You ZB. et al., 2007, Neoplasia. 9 (6): 464-70.
3. Zrioual S. et al., 2008, J Immunol. 180 (1):655-63.
4. Kuestner RE. et al., 2010, J Immunol. 179 (8): 5462-73.